Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma.
|
28592523 |
2017 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
|
28146043 |
2017 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.
|
27287845 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
|
26775776 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.
|
26681309 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.
|
26681309 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.
|
26876133 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma.
|
26581427 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Germline hemizygous deletion of CDKN2A-CDKN2B locus in a patient presenting with Li-Fraumeni syndrome.
|
29263814 |
2016 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
|
26104880 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.
|
25803691 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.
|
25227142 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
|
25980754 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Germline mutations predisposing to non-small cell lung cancer.
|
25813228 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Novel CDKN2A mutations in Austrian melanoma patients.
|
26225579 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
|
25356972 |
2015 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Genotype analysis in Hungarian patients with multiple primary melanoma.
|
24660985 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
|
25064638 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
|
24935963 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment.
|
24659262 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.
|
25780468 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
|
24737347 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.
|
25780468 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
GeneticVariation
|
group |
CLINVAR |
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
|
24733792 |
2014 |
Neoplastic Syndromes, Hereditary
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome.
|
23613284 |
2013 |